Cann Group Ltd. ( (AU:CAN) ) has shared an announcement.
Cann Group Limited reported a 23.8% decrease in revenues from ordinary activities to $6.467 million for the half-year ended 31 December 2024. The company also recorded a loss of $10.698 million, down 25.4% from the previous period, with no dividends declared. The auditors noted a material uncertainty regarding the company’s ability to continue as a going concern, although their conclusion was not modified.
More about Cann Group Ltd.
Cann Group Limited operates in the medicinal cannabis industry, focusing on the cultivation and production of cannabis products for medical purposes.
YTD Price Performance: 70.0%
Average Trading Volume: 2,000
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $9.99M
For detailed information about CAN stock, go to TipRanks’ Stock Analysis page.